{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,27]],"date-time":"2025-12-27T21:11:23Z","timestamp":1766869883930,"version":"3.37.3"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2018,7,30]],"date-time":"2018-07-30T00:00:00Z","timestamp":1532908800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001407","name":"Department of Biotechnology, Ministry of Science and Technology","doi-asserted-by":"publisher","award":["BT\/PR15112\/GBD\/27\/323\/2011","BT\/BI\/25\/001\/2006"],"award-info":[{"award-number":["BT\/PR15112\/GBD\/27\/323\/2011","BT\/BI\/25\/001\/2006"]}],"id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Mol Neurobiol"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1007\/s10571-018-0605-6","type":"journal-article","created":{"date-parts":[[2018,7,30]],"date-time":"2018-07-30T01:23:00Z","timestamp":1532913780000},"page":"1383-1397","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["The Synergistic Combination of Everolimus and Paroxetine Exerts Post-ischemic Neuroprotection In Vitro"],"prefix":"10.1007","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9033-0422","authenticated-orcid":false,"given":"V. S.","family":"Suvanish Kumar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Etheresia","family":"Pretorius","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9754-997X","authenticated-orcid":false,"given":"G. K.","family":"Rajanikant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,7,30]]},"reference":[{"key":"605_CR1","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1093\/nar\/gkw985","volume":"45","author":"G Alanis-Lobato","year":"2017","unstructured":"Alanis-Lobato G, Andrade-Navarro MA, Schaefer MH (2017) HIPPIE v2.0: enhancing meaningfulness and reliability of protein-protein interaction networks. Nucleic Acids Res 45:408\u2013414. \n                    https:\/\/doi.org\/10.1093\/nar\/gkw985","journal-title":"Nucleic Acids Res"},{"key":"605_CR2","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/S0005-2728(03)00110-5","volume":"1606","author":"A Baracca","year":"2003","unstructured":"Baracca A, Sgarbi G, Solaini G, Lenaz G (2003) Rhodamine 123 as a probe of mitochondrial membrane potential: evaluation of proton flux through F(0) during ATP synthesis. Biochim et Biophys Acta 1606:137\u2013146","journal-title":"Biochim et Biophys Acta"},{"key":"605_CR3","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1161\/STROKEAHA.108.531632","volume":"40","author":"BRS Broughton","year":"2009","unstructured":"Broughton BRS, Reutens DC, Sobey CG (2009) Apoptotic mechanisms after cerebral ischemia. Stroke 40:331\u2013339. \n                    https:\/\/doi.org\/10.1161\/STROKEAHA.108.531632","journal-title":"Stroke"},{"key":"605_CR4","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.cell.2007.01.045","volume":"129","author":"JM Bruey","year":"2007","unstructured":"Bruey JM, Bruey-Sedano N, Luciano F et al (2007) Bcl-2 and Bcl-XL regulate proinflammatory caspase-1 activation by interaction with NALP1. Cell 129:45\u201356. \n                    https:\/\/doi.org\/10.1016\/j.cell.2007.01.045","journal-title":"Cell"},{"key":"605_CR5","doi-asserted-by":"publisher","first-page":"3810","DOI":"10.1128\/MCB.14.6.3810","volume":"14","author":"J C\u00e1rcamo","year":"1994","unstructured":"C\u00e1rcamo J, Weis FM, Ventura F et al (1994) Type I receptors specify growth-inhibitory and transcriptional responses to transforming growth factor beta and activin. Mol Cell Biol 14:3810\u20133821","journal-title":"Mol Cell Biol"},{"key":"605_CR6","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1515\/revneuro-2013-0046","volume":"25","author":"J Chen","year":"2014","unstructured":"Chen J (2014) Heme oxygenase in neuroprotection: from mechanisms to therapeutic implications. Rev Neurosci 25:269\u2013280. \n                    https:\/\/doi.org\/10.1515\/revneuro-2013-0046","journal-title":"Rev Neurosci"},{"key":"605_CR7","doi-asserted-by":"publisher","first-page":"3899","DOI":"10.1016\/j.febslet.2008.10.031","volume":"582","author":"H Chen","year":"2008","unstructured":"Chen H, Shi H (2008) A reducing environment stabilizes HIF-2alpha in SH-SY5Y cells under hypoxic conditions. FEBS Lett 582:3899\u201338902. \n                    https:\/\/doi.org\/10.1016\/j.febslet.2008.10.031","journal-title":"FEBS Lett"},{"key":"605_CR8","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1515\/revneuro-2012-0001","volume":"23","author":"H Chen","year":"2012","unstructured":"Chen H, Qu Y, Tang B et al (2012) Role of mammalian target of rapamycin in hypoxic or ischemic brain injury: potential neuroprotection and limitations. Rev Neurosci 23:279\u2013287. \n                    https:\/\/doi.org\/10.1515\/revneuro-2012-0001","journal-title":"Rev Neurosci"},{"key":"605_CR9","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1016\/j.cellsig.2013.03.017","volume":"25","author":"ZZ Chong","year":"2013","unstructured":"Chong ZZ, Yao Q, Li H-H (2013) The rationale of targeting mammalian target of rapamycin for ischemic stroke. Cell Signal 25:1598\u20131607. \n                    https:\/\/doi.org\/10.1016\/j.cellsig.2013.03.017","journal-title":"Cell Signal"},{"key":"605_CR10","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1124\/pr.58.3.10","volume":"58","author":"T-C Chou","year":"2006","unstructured":"Chou T-C (2006) Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies. Pharmacol Rev 58:621\u2013681. \n                    https:\/\/doi.org\/10.1124\/pr.58.3.10","journal-title":"Pharmacol Rev"},{"key":"605_CR11","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1158\/0008-5472.CAN-09-1947","volume":"70","author":"T-C Chou","year":"2010","unstructured":"Chou T-C (2010) Drug combination studies and their synergy quantification using the chou-talalay method. Can Res 70:440\u2013446. \n                    https:\/\/doi.org\/10.1158\/0008-5472.CAN-09-1947","journal-title":"Can Res"},{"key":"605_CR12","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.4049\/jimmunol.1000208","volume":"185","author":"YC Chung","year":"2010","unstructured":"Chung YC, Kim SR, Jin BK (2010) Paroxetine prevents loss of nigrostriatal dopaminergic neurons by inhibiting brain inflammation and oxidative stress in an experimental model of Parkinson\u2019s Disease. J Immunol 185:1230\u20131237. \n                    https:\/\/doi.org\/10.4049\/jimmunol.1000208","journal-title":"J Immunol"},{"key":"605_CR13","doi-asserted-by":"publisher","first-page":"2366","DOI":"10.1038\/nprot.2007.324","volume":"2","author":"MS Cline","year":"2007","unstructured":"Cline MS, Smoot M, Cerami E et al (2007) Integration of biological networks and gene expression data using Cytoscape. Nature Protoc 2:2366\u20132382. \n                    https:\/\/doi.org\/10.1038\/nprot.2007.324","journal-title":"Nature Protoc"},{"key":"605_CR14","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1111\/j.1750-3639.2000.tb00247.x","volume":"10","author":"G Zoppo del","year":"2000","unstructured":"del Zoppo G, Ginis I, Hallenbeck JM et al (2000) Inflammation and stroke: putative role for cytokines, adhesion molecules and iNOS in brain response to ischemia. Brain Pathol 10:95\u2013112","journal-title":"Brain Pathol"},{"key":"605_CR15","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.intimp.2015.02.029","volume":"25","author":"H Durairaj","year":"2015","unstructured":"Durairaj H, Steury MD, Parameswaran N (2015) Paroxetine differentially modulates LPS-induced TNF\u03b1 and IL-6 production in mouse macrophages. Int Immunopharmacol 25:485\u2013492. \n                    https:\/\/doi.org\/10.1016\/j.intimp.2015.02.029","journal-title":"Int Immunopharmacol"},{"key":"605_CR16","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1152\/ajpendo.00308.2012","volume":"304","author":"N Geary","year":"2013","unstructured":"Geary N (2013) Understanding synergy. AJP 304:237\u2013253. \n                    https:\/\/doi.org\/10.1152\/ajpendo.00308.2012","journal-title":"AJP"},{"key":"605_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms17050735","volume":"17","author":"S Granata","year":"2016","unstructured":"Granata S, Dalla Gassa A, Carraro A et al (2016) Sirolimus and everolimus pathway: reviewing candidate genes influencing their intracellular effects. Int J Mol Sciences 17:1\u201326. \n                    https:\/\/doi.org\/10.3390\/ijms17050735","journal-title":"Int J Mol Sciences"},{"key":"605_CR18","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/j.redox.2015.08.020","volume":"6","author":"DN Granger","year":"2015","unstructured":"Granger DN, Kvietys PR (2015) Reperfusion injury and reactive oxygen species: The evolution of a concept. Redox Biol 6:524\u2013551. \n                    https:\/\/doi.org\/10.1016\/j.redox.2015.08.020","journal-title":"Redox Biol"},{"key":"605_CR19","unstructured":"Harry GJ, Tilson HA (2010) Neurotoxicology. Informa Healthcare"},{"key":"605_CR20","doi-asserted-by":"crossref","unstructured":"Hasskarl J (2014) Everolimus. In: Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer. pp\u00a0373\u2013392","DOI":"10.1007\/978-3-642-54490-3_23"},{"key":"605_CR21","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1517\/13543784.8.4.417","volume":"8","author":"WE Heydorn","year":"1999","unstructured":"Heydorn WE (1999) Paroxetine: a review of its pharmacology, pharmacokinetics and utility in the treatment of a variety of psychiatric disorders. Expert Opin Investig Drugs 8:417\u2013441. \n                    https:\/\/doi.org\/10.1517\/13543784.8.4.417","journal-title":"Expert Opin Investig Drugs"},{"key":"605_CR22","doi-asserted-by":"crossref","unstructured":"Houghton PJ (2010) Everolimus. In: Clinical Cancer Research. \n                    http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20179227\n                    \n                  . Accessed 29 Jun 2017","DOI":"10.1158\/1078-0432.CCR-09-1314"},{"key":"605_CR23","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1227\/01.NEU.0000197333.55473.AD","volume":"58","author":"Y Hua","year":"2006","unstructured":"Hua Y, Wu J, Keep RF et al (2006) Tumor necrosis factor-\u03b1 increases in the brain after intracerebral hemorrhage and thrombin stimulation. Neurosurgery 58:542\u2013550. \n                    https:\/\/doi.org\/10.1227\/01.NEU.0000197333.55473.AD","journal-title":"Neurosurgery"},{"key":"605_CR24","doi-asserted-by":"publisher","first-page":"2413","DOI":"10.1093\/bioinformatics\/btx162","volume":"33","author":"A Ianevski","year":"2017","unstructured":"Ianevski A, He L, Aittokallio T, Tang J (2017) SynergyFinder: a web application for analyzing drug combination dose-response matrix data. Bioinformatics 33:2413\u20132415. \n                    https:\/\/doi.org\/10.1093\/bioinformatics\/btx162","journal-title":"Bioinformatics"},{"key":"605_CR25","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.2174\/1389450111009011517","volume":"11","author":"A Jazwa","year":"2010","unstructured":"Jazwa A, Cuadrado A (2010) Targeting heme oxygenase-1 for neuroprotection and neuroinflammation in neurodegenerative diseases. Curr Drug Targets 11:1517\u20131531","journal-title":"Curr Drug Targets"},{"key":"605_CR26","first-page":"1382","volume":"43","author":"WC Jean","year":"1998","unstructured":"Jean WC, Spellman SR, Nussbaum ES, Low WC (1998) Reperfusion injury after focal cerebral ischemia: the role of inflammation and the therapeutic horizon. Neurosurgery 43:1382\u20131397","journal-title":"Neurosurgery"},{"key":"605_CR27","doi-asserted-by":"publisher","first-page":"3055","DOI":"10.1101\/gad.1252404","volume":"18","author":"T Kamura","year":"2004","unstructured":"Kamura T, Maenaka K, Kotoshiba S et al (2004) VHL-box and SOCS-box domains determine binding specificity for Cul2-Rbx1 and Cul5-Rbx2 modules of ubiquitin ligases. Genes Dev 18:3055\u20133065. \n                    https:\/\/doi.org\/10.1101\/gad.1252404","journal-title":"Genes Dev"},{"key":"605_CR28","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1007\/s40263-014-0199-6","volume":"28","author":"K Kikuchi","year":"2014","unstructured":"Kikuchi K, Tanaka E, Murai Y, Tancharoen S (2014) Clinical Trials in Acute Ischemic Stroke. CNS Drugs 28:929\u2013938. \n                    https:\/\/doi.org\/10.1007\/s40263-014-0199-6","journal-title":"CNS Drugs"},{"key":"605_CR29","doi-asserted-by":"publisher","first-page":"2065","DOI":"10.2174\/0929867321666131228204246","volume":"21","author":"VSS Kumar","year":"2014","unstructured":"Kumar VSS, Gopalakrishnan A, Naziro\u011flu M, Rajanikant GK (2014) Calcium ion\u2014the key player in cerebral ischemia. Curr Med Chem 21:2065\u20132075","journal-title":"Curr Med Chem"},{"key":"605_CR30","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.cell.2012.03.017","volume":"149","author":"M Laplante","year":"2012","unstructured":"Laplante M, Sabatini DM (2012) mTOR signaling in growth control and disease. Cell 149:274\u2013293. \n                    https:\/\/doi.org\/10.1016\/j.cell.2012.03.017","journal-title":"Cell"},{"key":"605_CR31","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1186\/s12974-016-0709-1","volume":"13","author":"RH LeBlanc","year":"2016","unstructured":"LeBlanc RH, Chen R, Selim MH et al (2016) Heme oxygenase-1-mediated neuroprotection in subarachnoid hemorrhage via intracerebroventricular deferoxamine. J Neuroinflam 13:244\u2013253. \n                    https:\/\/doi.org\/10.1186\/s12974-016-0709-1","journal-title":"J Neuroinflam"},{"key":"605_CR32","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.1128\/MCB.17.3.1682","volume":"17","author":"JJ Lebrun","year":"1997","unstructured":"Lebrun JJ, Vale WW (1997) Activin and inhibin have antagonistic effects on ligand-dependent heteromerization of the type I and type II activin receptors and human erythroid differentiation. Mol Cell Biol 17:1682\u20131691","journal-title":"Mol Cell Biol"},{"key":"605_CR33","doi-asserted-by":"publisher","first-page":"121","DOI":"10.3164\/jcbn.10-29","volume":"47","author":"D-H Lee","year":"2010","unstructured":"Lee D-H, Lee YJ, Kwon KH (2010) Neuroprotective effects of astaxanthin in oxygen-glucose deprivation in SH-SY5Y cells and global cerebral ischemia in rat. Journal of Clin Biochem Nutr 47:121\u2013129. \n                    https:\/\/doi.org\/10.3164\/jcbn.10-29","journal-title":"Journal of Clin Biochem Nutr"},{"key":"605_CR34","doi-asserted-by":"publisher","first-page":"430","DOI":"10.3346\/jkms.2012.27.4.430","volume":"27","author":"B-S Lee","year":"2012","unstructured":"Lee B-S, Jun I-G, Kim S-H, Park JY (2012) Interaction of morphine and selective serotonin receptor inhibitors in rats experiencing inflammatory pain. J Korean Med Sci 27:430\u2013436. \n                    https:\/\/doi.org\/10.3346\/jkms.2012.27.4.430","journal-title":"J Korean Med Sci"},{"key":"605_CR35","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1248\/bpb.b14-00244","volume":"37","author":"SH Lee","year":"2014","unstructured":"Lee SH, Sung MJ, Lee HM et al (2014) Blockade of HERG human K+ channels by the antidepressant drug paroxetine. Biol Pharm Bull 37:1495\u20131504","journal-title":"Biol Pharm Bull"},{"key":"605_CR36","doi-asserted-by":"publisher","first-page":"2240","DOI":"10.3892\/etm.2016.3216","volume":"11","author":"CH Lee","year":"2016","unstructured":"Lee CH, Park JH, Ahn JH, Won M-H (2016) Effects of melatonin on cognitive impairment and hippocampal neuronal damage in a rat model of chronic cerebral hypoperfusion. Exp Ther Med 11:2240\u20132246. \n                    https:\/\/doi.org\/10.3892\/etm.2016.3216","journal-title":"Exp Ther Med"},{"key":"605_CR37","doi-asserted-by":"publisher","first-page":"3388","DOI":"10.1096\/fj.201600495R","volume":"30","author":"D Li","year":"2016","unstructured":"Li D, Wang C, Yao Y et al (2016) mTORC1 pathway disruption ameliorates brain inflammation following stroke via a shift in microglia phenotype from M1 type to M2 type. FASEB J 30:3388\u20133399. \n                    https:\/\/doi.org\/10.1096\/fj.201600495R","journal-title":"FASEB J"},{"key":"605_CR38","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/S0092-8674(00)80847-8","volume":"101","author":"SO Marx","year":"2000","unstructured":"Marx SO, Reiken S, Hisamatsu Y et al (2000) PKA phosphorylation dissociates FKBP12.6 from the calcium release channel (ryanodine receptor): defective regulation in failing hearts. Cell 101:365\u2013376","journal-title":"Cell"},{"key":"605_CR39","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.critrevonc.2007.03.001","volume":"64","author":"CT Noguchi","year":"2007","unstructured":"Noguchi CT, Asavaritikrai P, Teng R, Jia Y (2007) Role of erythropoietin in the brain. Crit Rev Oncol\/Hematol 64:159\u2013171. \n                    https:\/\/doi.org\/10.1016\/j.critrevonc.2007.03.001","journal-title":"Crit Rev Oncol\/Hematol"},{"key":"605_CR40","first-page":"1866","volume":"58","author":"WG North","year":"1998","unstructured":"North WG, Fay MJ, Longo KA, Du J (1998) Expression of all known vasopressin receptor subtypes by small cell tumors implies a multifaceted role for this neuropeptide. Can Res 58:1866\u20131871","journal-title":"Can Res"},{"key":"605_CR41","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1038\/jcbfm.2011.203","volume":"32","author":"VE O\u2019Collins","year":"2012","unstructured":"O\u2019Collins VE, Macleod MR, Donnan GA, Howells DW (2012) Evaluation of combination therapy in animal models of cerebral ischemia. J Cereb Blood Flow Metabol 32:585\u2013597. \n                    https:\/\/doi.org\/10.1038\/jcbfm.2011.203","journal-title":"J Cereb Blood Flow Metabol"},{"key":"605_CR42","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1593\/tlo.09277","volume":"3","author":"T O\u2019Reilly","year":"2010","unstructured":"O\u2019Reilly T, McSheehy PM (2010) Biomarker development for the clinical activity of the mTOR inhibitor everolimus (RAD001): processes, limitations, and further proposals. Transl Oncol 3:65\u201379","journal-title":"Transl Oncol"},{"key":"605_CR43","doi-asserted-by":"publisher","first-page":"10117","DOI":"10.1074\/jbc.M609157200","volume":"282","author":"K Ohnuma","year":"2007","unstructured":"Ohnuma K, Uchiyama M, Yamochi T et al (2007) Caveolin-1 Triggers T-cell Activation via CD26 in Association with CARMA1. J Biol Chem 282:10117\u201310131. \n                    https:\/\/doi.org\/10.1074\/jbc.M609157200","journal-title":"J Biol Chem"},{"key":"605_CR44","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1111\/j.1460-9568.2007.05636.x","volume":"26","author":"HJ Park","year":"2007","unstructured":"Park HJ, Lee PH, Ahn YW et al (2007) Neuroprotective effect of nicotine on dopaminergic neurons by anti-inflammatory action. Eur J Neurosci 26:79\u201389. \n                    https:\/\/doi.org\/10.1111\/j.1460-9568.2007.05636.x","journal-title":"Eur J Neurosci"},{"key":"605_CR45","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.yexcr.2004.01.024","volume":"295","author":"J-P Piret","year":"2004","unstructured":"Piret J-P, Lecocq C, Toffoli S et al (2004) Hypoxia and CoCl2 protect HepG2 cells against serum deprivation- and t-BHP-induced apoptosis: a possible anti-apoptotic role for HIF-1. Exp Cell Res 295:340\u2013349. \n                    https:\/\/doi.org\/10.1016\/j.yexcr.2004.01.024","journal-title":"Exp Cell Res"},{"key":"605_CR46","doi-asserted-by":"publisher","first-page":"40073","DOI":"10.18632\/oncotarget.9484","volume":"7","author":"L Raimondo","year":"2016","unstructured":"Raimondo L, D\u2019Amato V, Servetto A et al (2016) Everolimus induces Met inactivation by disrupting the FKBP12\/Met complex. Oncotarget 7:40073\u201340084. \n                    https:\/\/doi.org\/10.18632\/oncotarget.9484","journal-title":"Oncotarget"},{"key":"605_CR47","doi-asserted-by":"publisher","first-page":"2861","DOI":"10.1038\/sj.onc.1207523","volume":"23","author":"X Saelens","year":"2004","unstructured":"Saelens X, Festjens N, Walle L, Vande et al (2004) Toxic proteins released from mitochondria in cell death. Oncogene 23:2861\u20132874. \n                    https:\/\/doi.org\/10.1038\/sj.onc.1207523","journal-title":"Oncogene"},{"key":"605_CR48","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1111\/j.1349-7006.2005.00065.x","volume":"96","author":"E Sasabe","year":"2005","unstructured":"Sasabe E, Tatemoto Y, Li D et al (2005) Mechanism of HIF-1alpha-dependent suppression of hypoxia-induced apoptosis in squamous cell carcinoma cells. Cancer Sci 96:394\u2013402. \n                    https:\/\/doi.org\/10.1111\/j.1349-7006.2005.00065.x","journal-title":"Cancer Sci"},{"key":"605_CR49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0031826","volume":"7","author":"MH Schaefer","year":"2012","unstructured":"Schaefer MH, Fontaine J-F, Vinayagam A et al (2012) HIPPIE: integrating protein interaction networks with experiment based quality scores. PLoS ONE 7:1\u20138 (e31826. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0031826","journal-title":"PLoS ONE"},{"key":"605_CR50","doi-asserted-by":"publisher","first-page":"50636","DOI":"10.1074\/jbc.M209061200","volume":"277","author":"N Schwarzmann","year":"2002","unstructured":"Schwarzmann N, Kunerth S, Weber K et al (2002) Knock-down of the Type 3 Ryanodine Receptor Impairs Sustained Ca 2+ Signaling via the T Cell Receptor\/CD3 Complex. J Biol Chem 277:50636\u201350642. \n                    https:\/\/doi.org\/10.1074\/jbc.M209061200","journal-title":"J Biol Chem"},{"key":"605_CR51","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.exer.2007.05.004","volume":"85","author":"GD Sharma","year":"2007","unstructured":"Sharma GD, Kakazu A, Bazan HEP (2007) Protein kinase C alpha and epsilon differentially modulate hepatocyte growth factor-induced epithelial proliferation and migration. Exp Eye Res 85:289\u2013297. \n                    https:\/\/doi.org\/10.1016\/j.exer.2007.05.004","journal-title":"Exp Eye Res"},{"key":"605_CR52","doi-asserted-by":"publisher","first-page":"e00373","DOI":"10.1002\/brb3.373","volume":"5","author":"T Siepmann","year":"2015","unstructured":"Siepmann T, Penzlin AI, Kepplinger J et al (2015) Selective serotonin reuptake inhibitors to improve outcome in acute ischemic stroke: possible mechanisms and clinical evidence. Brain Behav 5:e00373. \n                    https:\/\/doi.org\/10.1002\/brb3.373","journal-title":"Brain Behav"},{"key":"605_CR53","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1007\/s13311-014-0315-9","volume":"12","author":"JP Steiner","year":"2015","unstructured":"Steiner JP, Bachani M, Wolfson-Stofko B et al (2015) Interaction of paroxetine with mitochondrial proteins mediates neuroprotection. Neurotherapeutics 12:200\u2013216. \n                    https:\/\/doi.org\/10.1007\/s13311-014-0315-9","journal-title":"Neurotherapeutics"},{"key":"605_CR54","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1161\/01.STR.32.7.1598","volume":"32","author":"Stroke Therapy Academic Industry Roundtable II (STAIR-II)","year":"2001","unstructured":"Stroke Therapy Academic Industry Roundtable II (STAIR-II) (2001) Recommendations for clinical trial evaluation of acute stroke therapies. Stroke 32:1598\u20131606","journal-title":"Stroke"},{"key":"605_CR55","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/0471250953.bi0813s47","volume":"47","author":"G Su","year":"2014","unstructured":"Su G, Morris JH, Demchak B, Bader GD (2014) Biological network exploration with Cytoscape 3. Curr Protoc Bioinform 47:1\u20138. \n                    https:\/\/doi.org\/10.1002\/0471250953.bi0813s47","journal-title":"Curr Protoc Bioinform"},{"key":"605_CR56","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1177\/1756285611434926","volume":"5","author":"N Subir\u00f3s","year":"2012","unstructured":"Subir\u00f3s N, Garc\u00eda D, Coro-Antich RM et al (2012) Erythropoietin: still on the neuroprotection road. Ther Adv Neurol Disord 5:161\u2013173. \n                    https:\/\/doi.org\/10.1177\/1756285611434926","journal-title":"Ther Adv Neurol Disord"},{"key":"605_CR57","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.1161\/01.STR.0000173406.04891.8c","volume":"36","author":"Y Sun","year":"2005","unstructured":"Sun Y, Calvert JW, Zhang JH (2005) Neonatal hypoxia\/ischemia is associated with decreased inflammatory mediators after erythropoietin administration. Stroke 36:1672\u20131678. \n                    https:\/\/doi.org\/10.1161\/01.STR.0000173406.04891.8c","journal-title":"Stroke"},{"key":"605_CR58","first-page":"81","volume":"9","author":"LH Toledo-Pereyra","year":"2004","unstructured":"Toledo-Pereyra LH, Lopez-Neblina F, Toledo AH (2004) Reactive oxygen species and molecular biology of ischemia\/reperfusion. Ann Transpl 9:81\u201383","journal-title":"Ann Transpl"},{"key":"605_CR59","doi-asserted-by":"publisher","first-page":"3423","DOI":"10.1091\/mbc.e06-04-0371","volume":"17","author":"WY Tsang","year":"2006","unstructured":"Tsang WY, Spektor A, Luciano DJ et al (2006) CP110 cooperates with two calcium-binding proteins to regulate cytokinesis and genome stability. Mol Biol Cell 17:3423\u20133434. \n                    https:\/\/doi.org\/10.1091\/mbc.E06-04-0371","journal-title":"Mol Biol Cell"},{"key":"605_CR60","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1084\/jem.20021067","volume":"198","author":"P Villa","year":"2003","unstructured":"Villa P, Bigini P, Mennini T et al (2003) Erythropoietin selectively attenuates cytokine production and inflammation in cerebral ischemia by targeting neuronal apoptosis. J Exp Med 198:971\u2013975. \n                    https:\/\/doi.org\/10.1084\/jem.20021067","journal-title":"J Exp Med"},{"key":"605_CR61","doi-asserted-by":"publisher","DOI":"10.1002\/jcb.22521","author":"SD Wenker","year":"2010","unstructured":"Wenker SD, Chamorro ME, Vota DM et al (2010) Differential antiapoptotic effect of erythropoietin on undifferentiated and retinoic acid-differentiated SH-SY5Y cells. J Cell Biochem. \n                    https:\/\/doi.org\/10.1002\/jcb.22521","journal-title":"J Cell Biochem"},{"key":"605_CR62","first-page":"93","volume":"86","author":"L Yin","year":"2003","unstructured":"Yin L, Ohtaki H, Nakamachi T et al (2003) Expression of tumor necrosis factor alpha (TNFalpha) following transient cerebral ischemia. Acta Neurochir Suppl 86:93\u201396","journal-title":"Acta Neurochir Suppl"},{"key":"605_CR63","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1007\/BF03401781","volume":"6","author":"R Zamora","year":"2000","unstructured":"Zamora R, Vodovotz Y, Billiar TR (2000) Inducible nitric oxide synthase and inflammatory diseases. Mol Med 6:347\u2013373","journal-title":"Mol Med"},{"key":"605_CR64","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1038\/ncb1291","volume":"7","author":"H Zhang","year":"2005","unstructured":"Zhang H, Kim JK, Edwards CA et al (2005) Clusterin inhibits apoptosis by interacting with activated Bax. Nat Cell Biol 7:909\u2013915. \n                    https:\/\/doi.org\/10.1038\/ncb1291","journal-title":"Nat Cell Biol"},{"key":"605_CR65","doi-asserted-by":"publisher","first-page":"8251","DOI":"10.7314\/APJCP.2014.15.19.8251","volume":"15","author":"B Zhang","year":"2014","unstructured":"Zhang B, Yin C-P, Zhao Q, Yue S-W (2014) Upregulation of HIF-1\u03b1 by hypoxia protect neuroblastoma cells from apoptosis by promoting survivin expression. Asian Pac J Cancer Prev 15:8251\u20138257","journal-title":"Asian Pac J Cancer Prev"},{"key":"605_CR66","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1177\/1087057114521867","volume":"19","author":"W Zhao","year":"2014","unstructured":"Zhao W, Sachsenmeier K, Zhang L et al (2014) A new bliss independence model to analyze drug combination data. J Biomol Screen 19:817\u2013821. \n                    https:\/\/doi.org\/10.1177\/1087057114521867","journal-title":"J Biomol Screen"},{"key":"605_CR67","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.3892\/etm.2014.1564","volume":"7","author":"L Zhu","year":"2014","unstructured":"Zhu L, Bi W, Lu D et al (2014) Luteolin inhibits SH-SY5Y cell apoptosis through suppression of the nuclear transcription factor-\u03baB, mitogen-activated protein kinase and protein kinase B pathways in lipopolysaccharide-stimulated cocultured BV2 cells. Exp Ther Med 7:1065\u20131070. \n                    https:\/\/doi.org\/10.3892\/etm.2014.1564","journal-title":"Exp Ther Med"}],"container-title":["Cellular and Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10571-018-0605-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10571-018-0605-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10571-018-0605-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,22]],"date-time":"2019-09-22T06:38:59Z","timestamp":1569134339000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10571-018-0605-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,30]]},"references-count":67,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["605"],"URL":"https:\/\/doi.org\/10.1007\/s10571-018-0605-6","relation":{},"ISSN":["0272-4340","1573-6830"],"issn-type":[{"type":"print","value":"0272-4340"},{"type":"electronic","value":"1573-6830"}],"subject":[],"published":{"date-parts":[[2018,7,30]]},"assertion":[{"value":"10 March 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}